ASX - By Stock
|
OSL |
Re:
Ann: OncoSil TGA regulatory update
|
|
hyper41
|
39 |
25K |
5 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
39
|
25K
|
5
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil TGA regulatory update
|
|
hyper41
|
39 |
25K |
2 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
39
|
25K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil TGA regulatory update
|
|
hyper41
|
39 |
25K |
0 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
39
|
25K
|
0
|
|
ASX - By Stock
|
BCB |
Re:
Ann: Quarterly Activities Report
|
|
hyper41
|
90 |
23K |
0 |
01/06/21 |
01/06/21 |
ASX - By Stock
|
90
|
23K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
The dawn of OSL
|
|
hyper41
|
22 |
14K |
4 |
31/05/21 |
31/05/21 |
ASX - By Stock
|
22
|
14K
|
4
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Enterprise Well Initial Drill Permit Submitted
|
|
hyper41
|
505 |
151K |
6 |
16/05/21 |
16/05/21 |
ASX - By Stock
|
505
|
151K
|
6
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil Hong Kong Approval Status
|
|
hyper41
|
10 |
6.2K |
1 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
10
|
6.2K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil Hong Kong Approval Status
|
|
hyper41
|
10 |
6.2K |
3 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
10
|
6.2K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Appendix 4C - quarterly
|
|
hyper41
|
6 |
3.7K |
7 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
6
|
3.7K
|
7
|
|
ASX - By Stock
|
OSL |
Re:
Article Supporting Oncosil Trial
|
|
hyper41
|
21 |
9.1K |
2 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
21
|
9.1K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
hyper41
|
60 |
30K |
0 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
60
|
30K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
The London Clinic
|
|
hyper41
|
3 |
2.4K |
5 |
24/03/21 |
24/03/21 |
ASX - By Stock
|
3
|
2.4K
|
5
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
hyper41
|
60 |
30K |
1 |
21/03/21 |
21/03/21 |
ASX - By Stock
|
60
|
30K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
hyper41
|
60 |
30K |
1 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
60
|
30K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
hyper41
|
60 |
30K |
0 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
60
|
30K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
hyper41
|
60 |
30K |
0 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
60
|
30K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
hyper41
|
60 |
30K |
8 |
27/02/21 |
27/02/21 |
ASX - By Stock
|
60
|
30K
|
8
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
hyper41
|
60 |
30K |
1 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
60
|
30K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
hyper41
|
60 |
30K |
0 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
60
|
30K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
hyper41
|
60 |
30K |
0 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
60
|
30K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
hyper41
|
60 |
30K |
5 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
60
|
30K
|
5
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil Investor Update
|
|
hyper41
|
23 |
12K |
0 |
20/02/21 |
20/02/21 |
ASX - By Stock
|
23
|
12K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil Investor Update
|
|
hyper41
|
23 |
12K |
5 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
23
|
12K
|
5
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil Investor Update
|
|
hyper41
|
23 |
12K |
2 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
23
|
12K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil FY21 half yearly review
|
|
hyper41
|
34 |
19K |
1 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
34
|
19K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil FY21 half yearly review
|
|
hyper41
|
34 |
19K |
0 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
34
|
19K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil FY21 half yearly review
|
|
hyper41
|
34 |
19K |
2 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
34
|
19K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil FY21 half yearly review
|
|
hyper41
|
34 |
19K |
0 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
34
|
19K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil FY21 half yearly review
|
|
hyper41
|
34 |
19K |
0 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
34
|
19K
|
0
|
|
ASX - By Stock
|
BNL |
Re:
BNL Back to 5 and beyond
|
|
hyper41
|
9 |
2.5K |
4 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
9
|
2.5K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil FY21 half yearly review
|
|
hyper41
|
34 |
19K |
1 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
34
|
19K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil FY21 half yearly review
|
|
hyper41
|
34 |
19K |
0 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
34
|
19K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil FY21 half yearly review
|
|
hyper41
|
34 |
19K |
0 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
34
|
19K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil FY21 half yearly review
|
|
hyper41
|
34 |
19K |
2 |
19/01/21 |
19/01/21 |
ASX - By Stock
|
34
|
19K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil FY21 half yearly review
|
|
hyper41
|
34 |
19K |
3 |
19/01/21 |
19/01/21 |
ASX - By Stock
|
34
|
19K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil FY21 half yearly review
|
|
hyper41
|
34 |
19K |
0 |
19/01/21 |
19/01/21 |
ASX - By Stock
|
34
|
19K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil FY21 half yearly review
|
|
hyper41
|
34 |
19K |
13 |
18/01/21 |
18/01/21 |
ASX - By Stock
|
34
|
19K
|
13
|
|
ASX - By Stock
|
BNL |
Re:
BNL Friday lift to 5
|
|
hyper41
|
114 |
40K |
6 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
114
|
40K
|
6
|
|
ASX - By Stock
|
OSL Biotech |
Re:
$1 Party
|
|
hyper41
|
21 |
15K |
2 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
21
|
15K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil achieves first commercial sale
|
|
hyper41
|
42 |
14K |
3 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
42
|
14K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil achieves first commercial sale
|
|
hyper41
|
42 |
14K |
3 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
42
|
14K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
OSL Chart
|
|
hyper41
|
114 |
78K |
0 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
114
|
78K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
OSL Chart
|
|
hyper41
|
114 |
78K |
0 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
114
|
78K
|
0
|
|
ASX - By Stock
|
ORR |
Re:
Growth
|
|
hyper41
|
22 |
14K |
1 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
22
|
14K
|
1
|
|
ASX - By Stock
|
ORR |
Re:
Growth
|
|
hyper41
|
22 |
14K |
1 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
22
|
14K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Buy Signal
|
|
hyper41
|
36 |
15K |
2 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
36
|
15K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Buy Signal
|
|
hyper41
|
36 |
15K |
1 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
36
|
15K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Buy Signal
|
|
hyper41
|
36 |
15K |
1 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
36
|
15K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Update - Conference Call Notification
|
|
hyper41
|
26 |
8.9K |
0 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
26
|
8.9K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
OSL Chart
|
|
hyper41
|
114 |
78K |
0 |
28/08/20 |
28/08/20 |
ASX - By Stock
|
114
|
78K
|
0
|
|